<DOC>
	<DOCNO>NCT02349165</DOCNO>
	<brief_summary>The gold standard corneal crosslinking ( CXL ) technique involve initial step epithelial removal , order achieve sufficient treatment effect ( meaning : stabilisation progressive keratoconus ( KC ) . Our aim evaluate effect transepithelial CXL ( TE-CXL ) , whereby epithelium leave intact cornea instead treat solution compose 0.1 % riboflavin , combine enhancer , standard CXL perform . This solution seem facilitate riboflavin penetration corneal stroma intact epithelium . The investigator expect achieve similar effect TE-CXL advantage faster heal time less risk infection .</brief_summary>
	<brief_title>Standard Versus Transepithelial Corneal Crosslinking</brief_title>
	<detailed_description />
	<mesh_term>Keratoconus</mesh_term>
	<mesh_term>Riboflavin</mesh_term>
	<criteria>Documented progressive KC ( Pentacam and/or corneal topography imaging ) . A clear central cornea . A minimal corneal thickness ≥ 400 µm thinnest corneal location ( Pentacam image ) . Minimal Snellen correct distance visual acuity ≥ 0.4 . Patient age ≥ 18 year . For research study , inclusion parameter mention , follow additional inclusion criterion : Documented progression KC , demonstrate anterior segment image and/or corneal topography : Defined increase maximal keratometry , steep keratometry , mean keratometry topographic cylinder value ≥ 0.5 D previous 6 month and/or decrease thin pachymetry Documented progression KC define increase refractive cylinder ≥ 0.5 D previous 6 month Presence corneal scar . History epithelial healing problem . Presence previous ocular infection ( herpes keratitis ) . Patients pregnant and/or breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>